Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acylation and Crystallization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112679525B reveals a novel D-7ACA route for cefuroxime acid. Enhanced stability and crystal size offer cost reduction in API manufacturing.
Patent CN105859747B details high-purity Cefepime Hydrochloride production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN105859747A reveals a low-cost anhydrous refining process for high-purity Cefepime, ensuring supply chain stability and reduced manufacturing expenses.
Patent CN105924487B reveals a low-temperature acylation process for high-purity hormonal intermediates, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN1219531A enables high-yield hydroquinone diester production via simplified crystallization, offering significant cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN116925093A details a refined irinotecan synthesis using 1-methylpyrrolidine. This method offers cost reduction and scalable manufacturing for pharmaceutical intermediates.